PRWLX | VTISX | PRWLX / VTISX | |
Total Expense Ratio | 1.19 | 0.05 | 2,532% |
Annual Report Gross Expense Ratio | 1.19 | 0.05 | 2,532% |
Fund Existence | 20 years | 9 years | - |
Gain YTD | 18.045 | 18.319 | 99% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 3000000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.17B | 511B | 0% |
Annual Yield % from dividends | 1.76 | 2.85 | 62% |
Returns for 1 year | 12.33 | 15.03 | 82% |
Returns for 3 years | 38.67 | 34.09 | 113% |
Returns for 5 years | 33.28 | 38.03 | 88% |
Returns for 10 years | 51.07 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MTUL | 34.91 | N/A | N/A |
ETRACS 2x Lvrgd MSCI US Mntm Fctr TR ETN | |||
DMO | 11.81 | -0.01 | -0.13% |
Western Asset Mortgage Opportunity Fund | |||
RSJN | 33.34 | -0.08 | -0.23% |
FT Vest U.S. Eq Eq Wght Buffr ETF - Jun | |||
DFLV | 31.84 | -0.17 | -0.53% |
Dimensional US Large Cap Value ETF | |||
PPH | 88.45 | -1.22 | -1.36% |
VanEck Pharmaceutical ETF |